{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:23:18Z","timestamp":1780579398280,"version":"3.54.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005747","name":"A.P. M\u00f8ller og Hustru Chastine Mc-Kinney M\u00f8llers Fond til almene Formaal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006197","name":"Fonden til L\u00e6gevidenskabens Fremme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006356","name":"Syddansk Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006356","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007438","name":"Familien Hede Nielsens Fond","doi-asserted-by":"publisher","award":["S-20120209"],"award-info":[{"award-number":["S-20120209"]}],"id":[{"id":"10.13039\/501100007438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004196","name":"Odense Universitetshospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003035","name":"Aase og Ejnar Danielsens Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pet.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["PET Clinics"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.cpet.2019.03.004","type":"journal-article","created":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T03:16:16Z","timestamp":1554866176000},"page":"341-352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Evolving Roles of Fluorodeoxyglucose and Sodium Fluoride in Assessment of Multiple Myeloma Patients"],"prefix":"10.1016","volume":"14","author":[{"given":"Mahdi Zirakchian","family":"Zadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William Y.","family":"Raynor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siavash Mehdizadeh","family":"Seraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrus","family":"Ayubcha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esha","family":"Kothekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abass","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cpet.2019.03.004_bib1","first-page":"7","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cpet.2019.03.004_bib2","doi-asserted-by":"crossref","first-page":"17046","DOI":"10.1038\/nrdp.2017.46","article-title":"Multiple myeloma","volume":"3","author":"Kumar","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"10.1016\/j.cpet.2019.03.004_bib3","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.cpet.2019.03.004_bib4","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3324\/haematol.2015.129189","article-title":"Treatment of relapsed and refractory multiple myeloma","volume":"101","author":"Sonneveld","year":"2016","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.cpet.2019.03.004_bib5","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/annonc\/mdi235","article-title":"Myeloma bone disease: pathophysiology and management","volume":"16","author":"Terpos","year":"2005","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.cpet.2019.03.004_bib6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2141.1982.tb03936.x","article-title":"Quantitative histology of myeloma-induced bone changes","volume":"52","author":"Valentin-Opran","year":"1982","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.cpet.2019.03.004_bib7","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1600-0609.1992.tb00046.x","article-title":"Abnormal bone remodelling in patients with myelomatosis and normal biochemical indices of bone resorption","volume":"49","author":"Taube","year":"1992","journal-title":"Eur J Haematol"},{"issue":"1","key":"10.1016\/j.cpet.2019.03.004_bib8","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1172\/JCI115305","article-title":"Recruitment of new osteoblasts and osteoclasts is the earliest critical event in the pathogenesis of human multiple myeloma","volume":"88","author":"Bataille","year":"1991","journal-title":"J\u00a0Clin Invest"},{"issue":"9","key":"10.1016\/j.cpet.2019.03.004_bib9","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/leu.2009.89","article-title":"International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple myeloma","volume":"23","author":"Dimopoulos","year":"2009","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.cpet.2019.03.004_bib10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2141.2007.06491.x","article-title":"Guidelines for the use of imaging in the management of myeloma","volume":"137","author":"D'Sa","year":"2007","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.cpet.2019.03.004_bib11","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0009-9260(67)80010-2","article-title":"The radiological demonstration of osseous metastases. Experimental observations","volume":"18","author":"Edelstyn","year":"1967","journal-title":"Clin Radiol"},{"issue":"4","key":"10.1016\/j.cpet.2019.03.004_bib12","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1016\/S1470-2045(17)30189-4","article-title":"Role of (18)F-FDG PET\/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group","volume":"18","author":"Cavo","year":"2017","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.cpet.2019.03.004_bib13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11914-016-0312-5","article-title":"Evolving role of molecular imaging with (18)F-sodium fluoride PET as a biomarker for calcium metabolism","volume":"14","author":"Raynor","year":"2016","journal-title":"Curr Osteoporos Rep"},{"issue":"10","key":"10.1016\/j.cpet.2019.03.004_bib14","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/MNM.0000000000000891","article-title":"Quantitative evaluation of normal spinal osseous metabolism with 18F-NaF PET\/CT","volume":"39","author":"Ayubcha","year":"2018","journal-title":"Nucl Med Commun"},{"issue":"11","key":"10.1016\/j.cpet.2019.03.004_bib15","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.2967\/jnumed.110.082263","article-title":"SNM practice guideline for sodium 18F-fluoride PET\/CT bone scans 1.0","volume":"51","author":"Segall","year":"2010","journal-title":"J\u00a0Nucl Med"},{"issue":"11","key":"10.1016\/j.cpet.2019.03.004_bib16","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1007\/s00259-015-3138-y","article-title":"(18)F-NaF PET\/CT: EANM procedure guidelines for bone imaging","volume":"42","author":"Beheshti","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.cpet.2019.03.004_bib17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2967\/jnumed.106.037200","article-title":"Skeletal PET with 18F-fluoride: applying new technology to an old tracer","volume":"49","author":"Grant","year":"2008","journal-title":"J\u00a0Nucl Med"},{"issue":"Suppl 1","key":"10.1016\/j.cpet.2019.03.004_bib18","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","article-title":"From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors","volume":"50","author":"Wahl","year":"2009","journal-title":"J\u00a0Nucl Med"},{"issue":"1","key":"10.1016\/j.cpet.2019.03.004_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00259-015-3182-7","article-title":"The engagement of FDG PET\/CT image quality and harmonized quantification: from competitive to complementary","volume":"43","author":"Boellaard","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.cpet.2019.03.004_bib20","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1148\/rg.2016150102","article-title":"Role of optimal quantification of FDG PET imaging in the clinical practice of radiology","volume":"36","author":"Ziai","year":"2016","journal-title":"Radiographics"},{"issue":"3","key":"10.1016\/j.cpet.2019.03.004_bib21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s40336-014-0065-z","article-title":"Trends in PET quantification: opportunities and challenges","volume":"2","author":"Zaidi","year":"2014","journal-title":"Clin Transl Imaging"},{"issue":"4","key":"10.1016\/j.cpet.2019.03.004_bib22","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2214\/AJR.07.2635","article-title":"Whole-body MRI versus whole-body MDCT for staging of multiple myeloma","volume":"190","author":"Baur-Melnyk","year":"2008","journal-title":"AJR Am J Roentgenol"},{"issue":"12","key":"10.1016\/j.cpet.2019.03.004_bib23","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00277-009-0829-0","article-title":"Role of radiography, MRI and FDG-PET\/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma","volume":"88","author":"Lutje","year":"2009","journal-title":"Ann Hematol"},{"issue":"8","key":"10.1016\/j.cpet.2019.03.004_bib24","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1002\/cncr.26467","article-title":"18F-fluoro-deoxyglucose positron emission tomography in assessment of myeloma-related bone disease: a systematic review","volume":"118","author":"Van Lammeren-Venema","year":"2012","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.cpet.2019.03.004_bib25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3324\/haematol.10554","article-title":"A\u00a0prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma","volume":"92","author":"Zamagni","year":"2007","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.cpet.2019.03.004_bib26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2967\/jnumed.107.045641","article-title":"18F-FDG PET\/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma","volume":"49","author":"Fonti","year":"2008","journal-title":"J\u00a0Nucl Med"},{"issue":"6","key":"10.1016\/j.cpet.2019.03.004_bib27","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.1097\/RLU.0000000000000773","article-title":"18F-FDG dynamic PET\/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate","volume":"40","author":"Sachpekidis","year":"2015","journal-title":"Clin Nucl Med"},{"issue":"5","key":"10.1016\/j.cpet.2019.03.004_bib28","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00259-005-0004-3","article-title":"Role of 18 F-FDG PET\/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results","volume":"33","author":"Nanni","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"10.1016\/j.cpet.2019.03.004_bib29","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s00256-006-0127-z","article-title":"Comparison of imaging with FDG PET\/CT with other imaging modalities in myeloma","volume":"35","author":"Breyer","year":"2006","journal-title":"Skeletal Radiol"},{"issue":"4","key":"10.1016\/j.cpet.2019.03.004_bib30","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/02841850801898625","article-title":"Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma","volume":"49","author":"Hur","year":"2008","journal-title":"Acta Radiol"},{"issue":"7","key":"10.1016\/j.cpet.2019.03.004_bib31","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00256-010-1088-9","article-title":"The value of FDG PET\/CT in the initial staging and bone marrow involvement of patients with multiple myeloma","volume":"40","author":"Sager","year":"2011","journal-title":"Skeletal Radiol"},{"issue":"12","key":"10.1016\/j.cpet.2019.03.004_bib32","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1016\/j.ejrad.2012.06.028","article-title":"Contrast enhanced MRI and 18F-FDG PET-CT in the assessment of multiple myeloma: a comparison of results in different phases of the disease","volume":"81","author":"Spinnato","year":"2012","journal-title":"Eur J Radiol"},{"issue":"4","key":"10.1016\/j.cpet.2019.03.004_bib33","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.2214\/ajr.184.4.01841199","article-title":"Value of FDG PET in the assessment of patients with multiple myeloma","volume":"184","author":"Bredella","year":"2005","journal-title":"Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.cpet.2019.03.004_bib34","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/bjh.12346","article-title":"Comparison of modern and conventional imaging techniques in establishing multiple myeloma-related bone disease: a systematic review","volume":"162","author":"Regelink","year":"2013","journal-title":"Br J Haematol"},{"issue":"25","key":"10.1016\/j.cpet.2019.03.004_bib35","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1200\/JCO.2017.72.2975","article-title":"Prospective evaluation of MRI and PET-CT at diagnosis and before maintenance therapy in symptomatic patients with multiple myeloma included in the IFM\/DFCI 2009 trial","volume":"35","author":"Moreau","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.cpet.2019.03.004_bib36","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s00259-014-2721-y","article-title":"PET\/CT studies of multiple myeloma using (18) F-FDG and (18) F-NaF: comparison of distribution patterns and tracers' pharmacokinetics","volume":"41","author":"Sachpekidis","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"10.1016\/j.cpet.2019.03.004_bib37","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00277-015-2410-3","article-title":"Is there any complimentary role of F-18 NaF PET\/CT in detecting of osseous involvement of multiple myeloma? A comparative study for F-18 FDG PET\/CT and F-18 FDG NaF PET\/CT","volume":"94","author":"Ak","year":"2015","journal-title":"Ann Hematol"},{"issue":"11","key":"10.1016\/j.cpet.2019.03.004_bib38","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/RLU.0000000000000908","article-title":"18F-FDG and 18F-NaF PET\/CT findings of a multiple myeloma patient with thyroid cartilage involvement","volume":"40","author":"Oral","year":"2015","journal-title":"Clin Nucl Med"},{"issue":"1","key":"10.1016\/j.cpet.2019.03.004_bib39","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00277-010-1037-7","article-title":"F-18 FDG uptake of bone marrow on PET\/CT scan: it's correlation with CD38\/CD138 expressing myeloma cells in bone marrow of patients with multiple myeloma","volume":"90","author":"Ak","year":"2011","journal-title":"Ann Hematol"},{"issue":"12","key":"10.1016\/j.cpet.2019.03.004_bib40","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.2967\/jnumed.108.056713","article-title":"Relationship between cancer type and impact of PET and PET\/CT on intended management: findings of the national oncologic PET registry","volume":"49","author":"Hillner","year":"2008","journal-title":"J\u00a0Nucl Med"},{"issue":"23","key":"10.1016\/j.cpet.2019.03.004_bib41","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.1182\/blood-2011-06-361386","article-title":"Prognostic relevance of 18-F FDG PET\/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation","volume":"118","author":"Zamagni","year":"2011","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.cpet.2019.03.004_bib42","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1182\/blood-2009-03-213280","article-title":"F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma","volume":"114","author":"Bartel","year":"2009","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.cpet.2019.03.004_bib43","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.2967\/jnumed.112.106500","article-title":"Metabolic tumor volume assessed by 18F-FDG PET\/CT for the prediction of outcome in patients with multiple myeloma","volume":"53","author":"Fonti","year":"2012","journal-title":"J\u00a0Nucl Med"},{"issue":"6","key":"10.1016\/j.cpet.2019.03.004_bib44","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1007\/s00259-011-1738-8","article-title":"Value of 18 F-fluorodeoxyglucose uptake in positron emission tomography\/computed tomography in predicting survival in multiple myeloma","volume":"38","author":"Haznedar","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"19","key":"10.1016\/j.cpet.2019.03.004_bib45","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1158\/1078-0432.CCR-15-0396","article-title":"PET\/CT improves the definition of complete response and allows to detect otherwise unidentifiable skeletal progression in multiple myeloma","volume":"21","author":"Zamagni","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.cpet.2019.03.004_bib46","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.bbmt.2015.03.001","article-title":"The role of positron emission tomography with 18F-fluorodeoxyglucose integrated with computed tomography in the evaluation of patients with multiple myeloma undergoing allogeneic stem cell transplantation","volume":"21","author":"Patriarca","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"17","key":"10.1016\/j.cpet.2019.03.004_bib47","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.18632\/oncotarget.2290","article-title":"18FDG-PET\/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantation","volume":"5","author":"Lapa","year":"2014","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.cpet.2019.03.004_bib48","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1182\/blood-2012-08-451690","article-title":"Prognostic implications of serial 18-fluoro-deoxyglucose emission tomography in multiple myeloma treated with total therapy 3","volume":"121","author":"Usmani","year":"2013","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.cpet.2019.03.004_bib49","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/RLU.0b013e3181b06bc5","article-title":"Prediction of progression-free survival in patients with multiple myeloma following anthracycline-based chemotherapy based on dynamic FDG-PET","volume":"34","author":"Dimitrakopoulou-Strauss","year":"2009","journal-title":"Clin Nucl Med"},{"issue":"21","key":"10.1016\/j.cpet.2019.03.004_bib50","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1182\/blood.V124.21.3983.3983","article-title":"Impact of PET-CT response on survival parameters following autologous stem cell transplantation among patients with multiple myeloma: comparison of two cut-off values","volume":"124","author":"Beksac","year":"2014","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cpet.2019.03.004_bib51","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1001\/jamaoncol.2015.2010","article-title":"Treatment with carfilzomib-lenalidomide-dexamethasone with lenalidomide extension in patients with smoldering or newly diagnosed multiple myeloma","volume":"1","author":"Korde","year":"2015","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.cpet.2019.03.004_bib52","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1097\/RLU.0b013e318266cee2","article-title":"The value of 18F-FDG PET\/CT after autologous stem cell transplantation (ASCT) in patients affected by multiple myeloma (MM): experience with 77 patients","volume":"38","author":"Nanni","year":"2013","journal-title":"Clin Nucl Med"},{"issue":"6","key":"10.1016\/j.cpet.2019.03.004_bib53","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/s11547-013-0946-7","article-title":"Whole-body MRI and PET\/CT in multiple myeloma patients during staging and after treatment: personal experience in a longitudinal study","volume":"118","author":"Cascini","year":"2013","journal-title":"Radiol Med"},{"issue":"8","key":"10.1016\/j.cpet.2019.03.004_bib54","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1016\/S1470-2045(16)30206-6","article-title":"International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma","volume":"17","author":"Kumar","year":"2016","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.cpet.2019.03.004_bib55","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1001\/jamaoncol.2016.3160","article-title":"Association of minimal residual disease with superior survival outcomes in patients with multiple myeloma: a meta-analysis","volume":"3","author":"Munshi","year":"2017","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.cpet.2019.03.004_bib56","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cpet.2018.08.005","article-title":"Metastatic seeding attacks bone marrow, not bone: rectifying ongoing misconceptions","volume":"14","author":"Raynor","year":"2019","journal-title":"PET Clin"},{"issue":"1","key":"10.1016\/j.cpet.2019.03.004_bib57","first-page":"9","article-title":"Temporal profile of fluorodeoxyglucose uptake in malignant lesions and normal organs over extended time periods in patients with lung carcinoma: implications for its utilization in assessing malignant lesions","volume":"53","author":"Basu","year":"2009","journal-title":"Q\u00a0J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.cpet.2019.03.004_bib58","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s002590050381","article-title":"Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer","volume":"26","author":"Boerner","year":"1999","journal-title":"Eur J Nucl Med"},{"issue":"1","key":"10.1016\/j.cpet.2019.03.004_bib59","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cpet.2015.07.003","article-title":"Dual-time-point imaging and delayed-time-point fluorodeoxyglucose-PET\/computed tomography imaging in various clinical settings","volume":"11","author":"Houshmand","year":"2016","journal-title":"PET Clin"},{"issue":"11","key":"10.1016\/j.cpet.2019.03.004_bib60","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.2967\/jnumed.111.093716","article-title":"Potential of dual-time-point imaging to improve breast cancer diagnosis with 18F-FDG PET","volume":"46","author":"Kumar","year":"2005","journal-title":"J\u00a0Nucl Med"},{"issue":"supplement 1","key":"10.1016\/j.cpet.2019.03.004_bib61","first-page":"188","article-title":"Correlation of dual time point FDG-PET with response to chemotherapy in multiple myeloma","volume":"58","author":"Taghvaei","year":"2017","journal-title":"J\u00a0Nucl Med"},{"issue":"1","key":"10.1016\/j.cpet.2019.03.004_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11307-017-1146-y","article-title":"Correction for partial volume effect is a must, not a luxury, to fully exploit the potential of quantitative PET imaging in clinical oncology","volume":"20","author":"Alavi","year":"2018","journal-title":"Mol Imaging Biol"},{"issue":"supplement 1","key":"10.1016\/j.cpet.2019.03.004_bib63","first-page":"1420","article-title":"Measuring bone marrow activity with FDG-PET in multiple myeloma, smoldering myeloma, and healthy subjects","volume":"59","author":"Raynor","year":"2018","journal-title":"J\u00a0Nucl Med"},{"issue":"supplement 1","key":"10.1016\/j.cpet.2019.03.004_bib64","first-page":"1430","article-title":"Changes in bone marrow FDG uptake in multiple myeloma patients before and after treatment","volume":"59","author":"Zadeh","year":"2018","journal-title":"J\u00a0Nucl Med"},{"issue":"supplement 1","key":"10.1016\/j.cpet.2019.03.004_bib65","first-page":"24","article-title":"Systemic bone remodeling in multiple myeloma, smoldering myeloma, and healthy subjects: global assessment with NaF-PET","volume":"59","author":"Raynor","year":"2018","journal-title":"J\u00a0Nucl Med"},{"issue":"11","key":"10.1016\/j.cpet.2019.03.004_bib66","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.115.020406","article-title":"Shared risk factors in cardiovascular disease and cancer","volume":"133","author":"Koene","year":"2016","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.cpet.2019.03.004_bib67","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1160\/TH13-02-0121","article-title":"The vulnerable coronary plaque: update on imaging technologies","volume":"110","author":"Rosa","year":"2013","journal-title":"Thromb Haemost"},{"issue":"8","key":"10.1016\/j.cpet.2019.03.004_bib68","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1161\/01.CIR.103.8.1051","article-title":"The impact of calcification on the biomechanical stability of atherosclerotic plaques","volume":"103","author":"Huang","year":"2001","journal-title":"Circulation"}],"container-title":["PET Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859819300203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859819300203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:07:04Z","timestamp":1761563224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556859819300203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1556859819300203"],"URL":"https:\/\/doi.org\/10.1016\/j.cpet.2019.03.004","relation":{},"ISSN":["1556-8598"],"issn-type":[{"value":"1556-8598","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolving Roles of Fluorodeoxyglucose and Sodium Fluoride in Assessment of Multiple Myeloma Patients","name":"articletitle","label":"Article Title"},{"value":"PET Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpet.2019.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}